Krystal Biotech, Inc. ($KRYS)
Filing Information
| Accession Number | 0001298709-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 3, 2026 |
| Document | View SEC Filing |
Transactions
15
Total Shares
201,923
Total Value
$8,430,173.76
P&L
+inf% (+$15,673,564.14)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Feb 27, 2026 | Exercise/Conversion | 8,750 | $0.00 | $0.00 | 1,486,806 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 27, 2026 | Tax Withholding | 3,981 | $275.64 | $1,097,322.84 | 1,482,825 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 27, 2026 | Exercise/Conversion | 26,250 | $0.00 | $0.00 | 1,509,075 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 27, 2026 | Tax Withholding | 11,942 | $275.64 | $3,291,692.88 | 1,497,133 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 27, 2026 | Exercise/Conversion | 5,725 | $0.00 | $0.00 | 1,502,858 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 27, 2026 | Tax Withholding | 2,605 | $275.64 | $718,042.20 | 1,500,253 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 27, 2026 | Exercise/Conversion | 22,500 | $0.00 | $0.00 | 1,436,211 | Indirect | By Spouse | View Details | |
Director | Common Stock | โ | Feb 27, 2026 | Tax Withholding | 10,236 | $275.64 | $2,821,451.04 | 1,425,975 | Indirect | By Spouse | View Details | |
Director | Common Stock | โ | Feb 27, 2026 | Exercise/Conversion | 4,000 | $0.00 | $0.00 | 1,429,975 | Indirect | By Spouse | View Details | |
Director | Common Stock | โ | Feb 27, 2026 | Tax Withholding | 1,820 | $275.64 | $501,664.80 | 1,428,155 | Indirect | By Spouse | View Details | |
Director | Restricted Stock Units | Derivative | Feb 27, 2026 | Exercise/Conversion | 8,750 | $0.00 | $0.00 | 17,500 | Direct | โ | View Details | |
Director | Performance Stock Units | Derivative | Feb 27, 2026 | Exercise/Conversion | 26,250 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Director | Restricted Stock Units | Derivative | Feb 27, 2026 | Exercise/Conversion | 5,725 | $0.00 | $0.00 | 17,175 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Feb 27, 2026 | Grant/Award | 45,249 | $0.00 | $0.00 | 45,249 | Direct | โ | View Details | |
Director | Restricted Stock Units | Derivative | Feb 27, 2026 | Grant/Award | 18,140 | $0.00 | $0.00 | 18,140 | Direct | โ | View Details |